Retatrutide

Description

In preclinical research models, Retatrutide is studied for its modulation of energy expenditure, glucose regulation, appetite signalling, and lipid metabolism. It features a C20 fatty diacid conjugation which promotes albumin binding and extended half-life in experimental models. Currently under evaluation in Phase III clinical trials (TRIUMPH programme).

Supplied as a lyophilised freeze-dried powder.

Technical Specifications:

• CAS Number: 2381089-83-2
• Molecular Formula: C221H342N46O68
• Molecular Weight: ~4,731 g/mol
• Peptide Length: 39 amino acids
• Receptor Targets: GLP-1R, GIPR, GCGR (triple agonist)
• Appearance: White lyophilised powder
• Vial Size: 10 mg
• Storage: -20°C long-term; 2–8°C after reconstitution. Protect from light.
• Reconstitution: Sterile bacteriostatic water
• Shelf Life: 36 months from manufacture (lyophilised)

Research Use Only. Not for human or animal consumption.